(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.

Autor: Tiepolt, Solveig1 (AUTHOR) Solveig.tiepolt@medizin.uni-leipzig.de, Becker, Georg-Alexander1 (AUTHOR), Wilke, Stephan1 (AUTHOR), Cecchin, Diego2 (AUTHOR), Rullmann, Michael1 (AUTHOR), Meyer, Philipp M.1 (AUTHOR), Barthel, Henryk1 (AUTHOR), Hesse, Swen1 (AUTHOR), Patt, Marianne1 (AUTHOR), Luthardt, Julia1 (AUTHOR), Wagenknecht, Gudrun3 (AUTHOR), Sattler, Bernhard1 (AUTHOR), Deuther-Conrad, Winnie4 (AUTHOR), Ludwig, Friedrich-Alexander4 (AUTHOR), Fischer, Steffen4 (AUTHOR), Gertz, Hermann-Josef5 (AUTHOR), Smits, René6 (AUTHOR), Hoepping, Alexander6 (AUTHOR), Steinbach, Jörg7 (AUTHOR), Brust, Peter4 (AUTHOR)
Zdroj: European Journal of Nuclear Medicine & Molecular Imaging. Mar2021, Vol. 48 Issue 3, p731-746. 16p. 1 Color Photograph, 1 Diagram, 5 Charts, 4 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje